Matches in Wikidata for { <http://www.wikidata.org/entity/Q92398837> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92398837 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92398837 description "scientific article published on 19 August 2019" @default.
- Q92398837 description "wetenschappelijk artikel" @default.
- Q92398837 description "наукова стаття, опублікована 19 серпня 2019" @default.
- Q92398837 name "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 name "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 type Item @default.
- Q92398837 label "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 label "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 prefLabel "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 prefLabel "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 P1433 Q92398837-BE919776-BBEA-48D7-8DAD-05FB276B25F5 @default.
- Q92398837 P1476 Q92398837-1BF2D1F1-6348-4F8B-A897-3462140AF36A @default.
- Q92398837 P2093 Q92398837-04EC4857-73FC-4035-89D8-5B8F14F4F2FB @default.
- Q92398837 P2093 Q92398837-181EF139-5007-450E-9B9A-87D1D348BE7A @default.
- Q92398837 P2093 Q92398837-260085F5-0192-4649-A056-E42D5DDD52C9 @default.
- Q92398837 P2093 Q92398837-3AFD494D-F926-451C-9DDD-8DE24242E79F @default.
- Q92398837 P2093 Q92398837-3E8A6F9F-47C5-466A-BB72-B28074EDBD14 @default.
- Q92398837 P2093 Q92398837-783BAEE5-2E10-4ADA-8E53-1BBAC4FF24CE @default.
- Q92398837 P2093 Q92398837-828B11D1-672D-4439-8AB1-240CA3DA69D5 @default.
- Q92398837 P2093 Q92398837-F091E9FA-A0CF-41FF-B46A-9039241E5BD0 @default.
- Q92398837 P304 Q92398837-EED3D711-BE40-49BF-9166-3F8FD7C8965D @default.
- Q92398837 P31 Q92398837-9F048367-F890-4663-96EF-51519BD8DBE2 @default.
- Q92398837 P356 Q92398837-F7B32CAD-EAE1-4C7C-8D4E-5F1A1B997F0D @default.
- Q92398837 P433 Q92398837-78E881E5-F03A-4F2C-A72F-6DD7AB949E9E @default.
- Q92398837 P478 Q92398837-A4539E9B-A1CF-45DB-BB60-D5E3FC77B444 @default.
- Q92398837 P50 Q92398837-C1D1620D-F275-445A-96A0-D88B975E6FEE @default.
- Q92398837 P577 Q92398837-513327EF-F571-47C6-9D43-E5B54DD4CA02 @default.
- Q92398837 P698 Q92398837-1E299C4F-FF47-4576-B14C-DFBA1631222E @default.
- Q92398837 P921 Q92398837-0080A23B-759B-4A1C-92DF-3C5085FDF293 @default.
- Q92398837 P921 Q92398837-E59A4315-E056-40CB-B432-5A295A09CDF2 @default.
- Q92398837 P356 AJH.25604 @default.
- Q92398837 P698 31378995 @default.
- Q92398837 P1433 Q4744246 @default.
- Q92398837 P1476 "Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism" @default.
- Q92398837 P2093 "Ana I Casanegra" @default.
- Q92398837 P2093 "Dalene M Bott-Kitslaar" @default.
- Q92398837 P2093 "Damon E Houghton" @default.
- Q92398837 P2093 "Danielle T Vlazny" @default.
- Q92398837 P2093 "David A Froehling" @default.
- Q92398837 P2093 "David O Hodge" @default.
- Q92398837 P2093 "Lisa G Peterson" @default.
- Q92398837 P2093 "Robert D Mcbane" @default.
- Q92398837 P304 "1185-1192" @default.
- Q92398837 P31 Q13442814 @default.
- Q92398837 P356 "10.1002/AJH.25604" @default.
- Q92398837 P433 "11" @default.
- Q92398837 P478 "94" @default.
- Q92398837 P50 Q43270883 @default.
- Q92398837 P577 "2019-08-19T00:00:00Z" @default.
- Q92398837 P698 "31378995" @default.
- Q92398837 P921 Q414462 @default.
- Q92398837 P921 Q9397786 @default.